MidEuropa Acquires Controlling Stake in FAMAR

FAMAR Acquires Homburg Sterile Manufacturing Site from MiP Pharma (MidEuropa-backed)

May 13, 2025

Pharmaceuticals

MidEuropa-backed portfolio company FAMAR signed an agreement to acquire a sterile manufacturing production site in Homburg (Saar), Germany from MiP Pharma. The addition expands FAMAR’s aseptic and lyophilised fill & finish capabilities and increases its European sterile manufacturing footprint to seven facilities, providing immediate capacity to serve international clients.

MidEuropa Acquires Majority Stake in the MBL Group

December 19, 2025

Medical Devices

MidEuropa has acquired a majority stake in the MBL Group, a leading European contract development and manufacturing organisation (CDMO) for assisted mobility, rehabilitation and aged-care equipment. INVL Baltic Sea Growth Fund has fully exited its shareholding while the Lauritsen family has reinvested and CEO Martin Lauritsen will continue to lead the business as MidEuropa supports international growth and capability expansion. MBL employs approximately 1,700 people across Europe and Asia and holds over 100 registered patents.

PerkinElmer Acquires Project Farma from Precision for Medicine

March 11, 2025

Healthcare Services

PerkinElmer has acquired Project Farma, a life‑sciences technical operations consultancy and subsidiary of Precision for Medicine, to expand its OneSource professional services offering. The acquisition brings Project Farma’s engineering, commissioning/qualification, project management and GMP facility experience into PerkinElmer’s lab services portfolio; terms were not disclosed.

Precision Medicine Group Acquires Project Farma

January 14, 2021

Healthcare Services

Precision Medicine Group has acquired Project Farma, a bioengineering services firm specializing in biomanufacturing strategy and facility implementation with a focus on cell and gene therapies. The deal brings Project Farma's manufacturing and scale-up expertise into Precision's cell and gene therapy services (Precision ADVANCE) to expand end-to-end development, manufacturing, and commercialization capabilities.

Abenex Continuation Fund Acquires Majority Stake in Europa Group; Europa Acquires APM International

April 29, 2024

Healthcare Services

Abenex closed an oversubscribed continuation fund (~€300m) to acquire a majority stake in Europa Group from its Abenex V portfolio, making Abenex the group's majority shareholder while founders remain significant owners and management continues. As part of its buy-and-build strategy supported by the recapitalization, Europa Group also acquired APM International (a France-based healthcare press agency) to strengthen its medical information and publishing capabilities.

STADA Acquires Walmark from MidEuropa

November 4, 2019

Consumer Products

STADA Arzneimittel AG has agreed to acquire Walmark a.s., a leading consumer healthcare company in Central Europe, from private equity firm MidEuropa Partners. The deal (consideration undisclosed) expands STADA's branded consumer health portfolio and strengthens its presence across Central and Eastern Europe; the transaction was expected to close in Q1 2020 subject to antitrust clearance.